Daily Cosmetic Research Analysis
Three studies with direct relevance to aesthetic and consumer-facing care stand out today: an evidence synthesis shows ultrasound-guided hyaluronidase achieves high resolution rates for impending filler-related facial skin necrosis; a systematic review supports combined microfocused ultrasound with visualization (MFU-V) plus calcium hydroxylapatite (CaHA-CMC) for skin laxity and quality; and an in vitro study flags common toothpaste flavoring/surfactant ingredients as irritants at typical use co
Summary
Three studies with direct relevance to aesthetic and consumer-facing care stand out today: an evidence synthesis shows ultrasound-guided hyaluronidase achieves high resolution rates for impending filler-related facial skin necrosis; a systematic review supports combined microfocused ultrasound with visualization (MFU-V) plus calcium hydroxylapatite (CaHA-CMC) for skin laxity and quality; and an in vitro study flags common toothpaste flavoring/surfactant ingredients as irritants at typical use concentrations on reconstructed human gingiva.
Research Themes
- Ultrasound-guided management of filler complications
- Combined energy-based device and biostimulatory filler therapies
- Cosmetic and oral care ingredient safety/toxicology
Selected Articles
1. Superior Outcomes with Ultrasound-Guided Hyaluronidase for Impending Filler-Induced Facial Skin Necrosis: A Systematic Review and Pilot Meta-Analysis.
Across four studies (n=55), ultrasound-guided hyaluronidase achieved a pooled complete resolution rate of 94.6% (95% CI 80.6–98.7%) for impending filler-induced facial skin necrosis. Evidence synthesis suggests improved outcomes compared with non-image-guided practices while potentially enabling lower hyaluronidase dosing. The review followed registered methods and graded certainty using GRADE.
Impact: This synthesis supports a practice-changing shift toward ultrasound guidance for urgent management of filler vascular compromise, with high success rates and likely lower enzyme doses.
Clinical Implications: Adopt ultrasound-guided hyaluronidase as first-line for suspected filler-induced ischemia; map vascular compromise, target injections, and consider lower dosing rather than blind high-dose flooding. Build training and protocols for point-of-care facial ultrasound in aesthetic practices.
Key Findings
- Pooled complete resolution after ultrasound-guided hyaluronidase was 94.6% (95% CI 80.6–98.7%) across 4 studies (55 patients).
- Image guidance has been associated with improved outcomes and lower hyaluronidase doses versus non-image-guided 'flooding' practices.
- Risk of bias was assessed with JBI tools and certainty rated with GRADE; protocol was registered (CRD42024585657).
Methodological Strengths
- Registered protocol and PRISMA-concordant systematic review with random-effects meta-analysis
- Bias assessment using JBI checklists and certainty grading via GRADE
Limitations
- Only four small observational studies (total n=55); no randomized comparisons
- Heterogeneity in ultrasound protocols, dosing, and timing; publication bias cannot be excluded
Future Directions: Prospective comparative studies and pragmatic trials to define optimal ultrasound protocols, dose–response, and time-to-treatment; development of training standards and reporting guidelines.
BACKGROUND: Hyaluronidase remains the mainstay treatment for impending filler-induced facial skin necrosis. Complete resolution of impending skin necrosis following hyaluronidase injection is estimated to be around 77.8%. Current practices are varied but most involve flooding 1500 international units (IU) of hyaluronidase into the suspect area. Image-guided hyaluronidase administration has shown improved outcomes with lower doses of hyaluronidase; however, no reviews have been conducted. OBJECTIVES: To characterize and establish the proportion of patients treated successfully with ultrasound-guided hyaluronidase for impending filler-induced facial skin necrosis. METHODS: This systematic review and meta-analysis queried four international databases from inception until September 2024 for sources including two or more patients receiving ultrasound-guided hyaluronidase for impending filler-induced facial skin necrosis. Random-effects (DerSimonian and Laird) meta-analyses were conducted. The primary outcome was the pooled proportion of complete scar resolution after ultrasound-guided hyaluronidase. The Joanna Briggs Institute checklists were utilized to assess intra-study risk of bias, and the certainty of evidence rated using the GRADE approach. RESULTS: Four studies totaling 55 patients were included in the analysis. The pooled proportion of complete scar resolution after ultrasound-guided hyaluronidase is probably 94.6% (95%-CI 80.6-98.7%, 4 studies, 55 patients, p CONCLUSION: Ultrasound-guided hyaluronidase represents a compelling step forward for complete resolution of impending filler-induced facial skin necrosis. Clinicians may wish to consider ultrasound-guided hyaluronidase as a first-line intervention considering the significant increase in the proportion of patients with better outcomes compared to non-image-guided intervention. More studies and higher-powered analyses are required to further confirm our findings. PROTOCOL REGISTRATION: CRD42024585657. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
2. Aesthetic Efficacy and Safety of Combined Microfocused Ultrasound With Visualization and Calcium Hydroxylapatite Treatment: A Systematic Review of Human Evidence.
Synthesizing 11 mainly pre–post human studies, combined MFU-V plus CaHA-CMC consistently improved global aesthetic scales, skin quality metrics, and patient satisfaction with mostly mild-to-moderate adverse effects. Histology indicated increased neocollagenesis and elastin synthesis following combination treatment. Evidence remains limited and heterogeneous, warranting controlled trials.
Impact: Provides the first consolidated clinical and mechanistic overview of a widely used combination strategy in aesthetic medicine, informing protocol design and patient counseling.
Clinical Implications: Combined MFU-V and CaHA-CMC can be considered for patients seeking skin laxity and quality improvements, with expectations set for mild-to-moderate, transient adverse effects. Histologic remodeling supports spacing treatments to leverage biostimulation.
Key Findings
- Across 11 studies, combined MFU-V + CaHA-CMC improved global aesthetic scales and skin quality metrics.
- Patient satisfaction improved following combination treatment, with adverse effects generally mild-to-moderate.
- Histologic data demonstrated increased neocollagenesis and elastin synthesis posttreatment.
Methodological Strengths
- Comprehensive multi-database search and systematic inclusion criteria
- Inclusion of both clinical outcomes and histologic evidence of remodeling
Limitations
- Predominance of uncontrolled pre–post designs; small sample sizes
- Heterogeneity in treatment parameters, areas treated, and outcome measures; potential publication bias
Future Directions: Randomized or controlled comparative trials of combination vs. monotherapies, standardized outcome measures, and dose-timing optimization.
Although microfocused ultrasound with visualization (MFU-V) and calcium hydroxylapatite- carboxymethylcellulose (CaHA-CMC) have their individual strengths and have demonstrated effectiveness in aesthetic improvement and improving skin laxity, a combined treatment may sometimes be required to achieve comprehensive aesthetic enhancements that meet patients' needs and preferences. This review systematically summarizes the available evidence on combined MFU-V and CaHA-CMC treatment. A comprehensive search was conducted in Embase, MEDLINE ALL (Ovid), Web of Science Core Collection, and Cochrane Central. We included studies conducted in adults that examined the effectiveness, safety, and/or mechanism of action of combined MFU-V and CaHA-CMC treatment. Out of 4019 references, 11 studies, mainly pre-post studies, were included in this analysis. Overall, regardless of the area treated, improvements in global aesthetic scales, skin quality parameters, and patients' satisfaction following combined treatment, accompanied by mild to moderate adverse effects, were found. In addition, histological studies indicated increased neocollagenesis and elastin synthesis posttreatment. Our review highlights promising outcomes from combined MFU-V and CaHA-CMC treatment. Nevertheless, due to the limited number of studies, further research is essential to gain a deeper understanding of this combined treatment's efficacy, safety, and applicability.
3. In vitro cytotoxicity (irritant potency) of toothpaste ingredients.
Using reconstructed human gingiva, the study quantified EC10/EC50 thresholds for common toothpaste ingredients. Lemon, peppermint, cinnamon, and SDS exceeded EC50 at concentrations present in toothpastes and caused histologic damage, whereas triclosan and fluoride exceeded EC10 but stayed below EC50 without clear histologic injury; xylitol, PEG, and SMP showed no adverse effects.
Impact: Findings directly inform formulation safety by identifying flavoring oils and SDS as potential oral mucosal irritants at typical toothpaste concentrations in a human tissue model.
Clinical Implications: For patients with mucosal sensitivity or stomatitis, consider recommending toothpaste without high concentrations of essential oils or SDS. Manufacturers should reassess concentrations of irritant-prone ingredients and adhere to higher safety standards.
Key Findings
- Xylitol, PEG, and sodium metaphosphate did not reduce cell viability or alter gingival tissue histology in RHG.
- Lemon, peppermint, cinnamon, and SDS exceeded EC50 at toothpaste-relevant concentrations and caused clear histologic damage.
- Triclosan and fluoride exceeded EC10 but remained below EC50, without clear histologic damage in RHG.
- EC10/EC50 thresholds were established using MTT assay with corroborating H&E histology.
Methodological Strengths
- Use of reconstructed human gingiva 3D tissue model with dose–response quantification (EC10/EC50)
- Histologic confirmation of cytotoxic effects via H&E staining
Limitations
- In vitro model may not fully capture in vivo saliva dilution, exposure dynamics, or repair
- Ingredient concentrations vary across products; lack of clinical correlation
Future Directions: Clinical studies correlating ingredient concentrations with oral mucosal symptoms; mixture effects and exposure-duration studies; reformulation trials reducing essential oil and SDS concentrations.
PURPOSE: This study aimed to determine the cytotoxicity (irritant potency) of toothpaste ingredients, of which some had known to have sensitizing properties. MATERIALS: From the wide variety of toothpaste ingredients, Xylitol, Propylene glycol (PEG), Sodium metaphosphate (SMP), Lemon, Peppermint, Fluoride, Cinnamon, and Triclosan and Sodium dodecyl sulphate (SDS) have been selected for evaluation of their cytotoxic properties. METHODS: Reconstructed human gingiva (RHG) were topically exposed to toothpaste ingredients at different concentrations. The compound concentration resulting in 50% cell death (EC50) and 10% cell death (EC10) was determined by the MTT assay. Detrimental effects in tissue histology were observed by hematoxylin & eosin staining of tissue sections followed by microscopy. RESULTS: While Xylitol, PEG, and SMP did not appear to affect cell viability or tissue histology, the concentrations of Lemon, Peppermint, Cinnamon and SDS present in toothpastes exceeded the EC50 value and resulted in clear detrimental effects in tissue histology, indicating that they could harm the oral mucosa. Triclosan and Fluoride concentrations in the tested toothpastes exceeded the EC10 value but remained below the EC50 value with no clear detrimental effects in tissue histology. CLINICAL SIGNIFICANCE: Manufacturers are encouraged to comply with higher standards of quality and safety for toothpaste.